EMA committee grants accelerated assessment to Novartis’ LCZ696 for heart failure
The accelerated review procedure is granted infrequently by the EMA and so far it has not been awarded in the cardiovascular area. The decision on European Union (EU)
The accelerated review procedure is granted infrequently by the EMA and so far it has not been awarded in the cardiovascular area. The decision on European Union (EU)
The IND filing for minocycline gel is part of the company’s strategy to develop improved drug delivery options for established drugs. Minocycline gel is a new formulation using
Supported by a grant from Eurostars, the project will combine Affibody’s proprietary platforms with Nordic’s radioimmunotherapy technology. Sweden’s Vinnova and the Norwegian Research Council have awarded around €1m
AVP-825 consists of low-dose sumatriptan powder delivered intranasally using a new Breath Powered delivery technology, for the treatment of migraine This delivery technology is activated by a user’s
aHUS is a severe and life-threatening ultra-rare disorder that affects around 200 people in England, with 20-30 new patients diagnosed with the condition each year. The disease causes
The move is claimed to be the first time in North America that people have been treated with the narcotic after being part of a clinical research trial,
Vargatef in combination with docetaxel is approved for use in adult patients with locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology,
At present, Dynavax has global rights to continue the development of DV1179 and other TLR 7/9 inhibitors for all indications. As part of the deal, Dynavax carried out
The trial showed bioequivalence between the liquid and lyophilised formulations of caplacizumab. To date, the liquid formulation has been used in clinical trials but the lyophilised form is
As part of the deal, Illumina will provide its research use only Nextera Rapid Capture Enrichment kits and NGS technology to a multi-arm, early-stage National Lung Matrix Trial